Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found. Tuesday’s report, from tests on more than 30,000 people in Iceland, is the most extensive work yet on the immune system’s response to the virus… Read More: Large antibody study offers hope for virus vaccine efforts »
AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people worldwide and 30,000 in the US as company signs £15million manufacturing deal Thousands volunteers already being injected with jab in UK, Brazil, South Africa Preliminary data from phase 3 trials expected ‘soon’, said lead jab researcher Developers say they hope to deliver the… Read More: AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling… »
Dr. Scott Gottlieb told CNBC on Monday the late-stage coronavirus vaccine trials underway in the U.S. are unlikely to have gathered enough evidence to receive emergency approval ahead of the November presidential election. “I think it’s very unlikely. I think it’s more likely you’re going to get a top-line result some point in November and maybe be… Read More: Coronavirus vaccine before election unlikely — Dr. Gottlieb on FDA… »
According to a study carried out by Lloyds Pharmacy 46% of Irish adults said they are planning on getting the flu vaccine this year. Research shows, 74 per cent of adults claim that the COVID-19 pandemic has made them more aware of the importance of being vaccinated against viruses. However, 46 per cent of adults… Read More: Less than half of Irish adults will get flu vaccine… »